Production (Stage)
GRI Bio, Inc.
GRI
$1.36
$0.064.62%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.28M | 5.03M | 4.75M | 6.35M | 4.09M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 649.00K | 587.00K | 577.00K | 531.00K | 337.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 3.93M | 5.62M | 5.32M | 6.88M | 4.43M |
|
|||||
Total Current Assets | 3.93M | 5.62M | 5.32M | 6.88M | 4.43M |
Net Property, Plant & Equipment | 112.00K | 124.00K | 136.00K | 147.00K | 159.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 4.04M | 5.74M | 5.46M | 7.03M | 4.59M |
|
|||||
Total Accounts Payable | 1.36M | 897.00K | 1.14M | 1.24M | 637.00K |
Total Accrued Expenses | 1.37M | 691.00K | 531.00K | 935.00K | 999.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 50.00K | 48.00K | 47.00K | 45.00K | 43.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 1.00K |
Total Other Current Liabilities | -- | -- | -- | -- | 1.00K |
Total Current Liabilities | 2.78M | 1.64M | 1.72M | 2.22M | 1.68M |
|
|||||
Total Current Liabilities | 2.78M | 1.64M | 1.72M | 2.22M | 1.68M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 58.00K | 71.00K | 84.00K | 96.00K | 109.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.84M | 1.71M | 1.80M | 2.31M | 1.79M |
|
|||||
Common Stock & APIC | 43.99M | 43.77M | 41.45M | 40.39M | 36.22M |
Retained Earnings | -42.79M | -39.74M | -37.79M | -35.67M | -33.42M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 1.21M | 4.03M | 3.66M | 4.72M | 2.80M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.21M | 4.03M | 3.66M | 4.72M | 2.80M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.21M | 4.03M | 3.66M | 4.72M | 2.80M |
|